Clinical Trial Update: NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating NOAC therapy guided by PARIS risk score and D-dimer in patients with acute coronary syndrome after PCI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Coronary Artery Disease, Percutaneous Coronary Intervention | Phase 4 | Status: RECRUITING